Learn more about the software development lifecycle to increase software safety reliability and compliance with international standards.
Our software development lifecycle (SDLC) training supports conformity to IEC 62304 and IEC 82304 standards.
Medical device makers doing business in the EU should become familiar with the regulatory requirement of providing an investigator’s brochure (IB).
The EC published its second overview of the Clinical Evaluation Consultation Procedure (CECP) (Article 54) of the Medical Devices Regulation (MDR) 2017/745.
Regulators are scrambling to confirm that their provisions regarding leveraging CE Marking Certificates are sufficiently aligned to Regulation 2023/607 by the May 26, 2024 deadline.
Medical device regulator ANVISA published new legislation allowing manufacturers of higher-risk devices to leverage registrations from some foreign regulatory authorities when applying for Brazil market access.
Manufacturers should commence their MDR and IVDR compliance journeys now. Emergo by UL recommends manufacturers review the guidance provided by their notified bodies as well as the Team NB Best Practice Guidance on the MDR Technical Documentation File (TDF) and similar guidance for the IVDR TDF.
Brazil’s medical device regulator ANVISA announced RDC 830/2023 becomes effective June 1, 2024, requiring manufacturers to assess gaps between RDC 36/2015 and RDC 830/2023, and review the classification of their IVDs.
In this on-demand webinar, our Emergo by UL subject matter expert will share insights on how to navigate laboratory-developed test manufacturers in the U.S.
On March 20, 2024, our Senior Research Director Merrick Kossack and Design Director Cory Costantino delivered a webinar on applying human factors engineering to software as a medical device. This debrief highlights some key topics presented.